㈜디티앤씨알오

{
  "address": "경기도 용인시",
  "ceo_name": "박채규",
  "certificate": [
    {
      "cert_number": "20170112119",
      "changes": "",
      "disclosure_date": "2017-10-20",
      "first_cert_date": "2017-10-20",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2017-10-20 ~ 2019-10-19"
    },
    {
      "cert_number": "20190113360",
      "changes": "",
      "disclosure_date": "2019-11-15",
      "first_cert_date": "2017-10-20",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2019-10-20 ~ 2021-10-19"
    },
    {
      "cert_number": "20211125030127",
      "changes": "",
      "disclosure_date": "2021-11-25",
      "first_cert_date": "2017-10-20",
      "no": "3",
      "type": "혁신성장유형",
      "valid_period": "2021-10-20 ~ 2024-10-19"
    },
    {
      "cert_number": "20241205030009",
      "changes": "소재지",
      "disclosure_date": "2024-12-05",
      "first_cert_date": "2017-10-20",
      "no": "4",
      "type": "혁신성장유형",
      "valid_period": "2024-10-20 ~ 2027-10-19"
    }
  ],
  "company_name": "㈜디티앤씨알오",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 3157628000,
      "cost_of_sales": 35032299000,
      "current_assets": 35877039000,
      "current_liabilities": 16540336000,
      "gross_profit": 8975401000,
      "net_income": 5290981000,
      "net_income_bs": 5255504000,
      "non_current_assets": 28657952000,
      "non_current_liabilities": 1674067000,
      "non_operating_expenses": 127431000,
      "non_operating_income": 124701000,
      "operating_profit": 5293711000,
      "revenue": 44007700000,
      "sga_expenses": 3681690000,
      "total_assets": 64534991000,
      "total_equity": 46320588000,
      "total_liabilities": 18214403000
    },
    "2023": {
      "capital_stock": 6365256000,
      "cost_of_sales": 33301430000,
      "current_assets": 17468313000,
      "current_liabilities": 15695691000,
      "gross_profit": -6715153000,
      "net_income": -17307025000,
      "net_income_bs": -16635631000,
      "non_current_assets": 42379576000,
      "non_current_liabilities": 12473275000,
      "non_operating_expenses": 5660357000,
      "non_operating_income": 478267000,
      "operating_profit": -12124935000,
      "revenue": 26586277000,
      "sga_expenses": 5409782000,
      "total_assets": 59847889000,
      "total_equity": 31678923000,
      "total_liabilities": 28168966000
    },
    "2024": {
      "capital_stock": 6385256000,
      "cost_of_sales": 39069488000,
      "current_assets": 19242729000,
      "current_liabilities": 34185411000,
      "gross_profit": -3098553000,
      "net_income": -1538574000,
      "net_income_bs": -1999170000,
      "non_current_assets": 61842970000,
      "non_current_liabilities": 18232885000,
      "non_operating_expenses": 2919664000,
      "non_operating_income": 12676259000,
      "operating_profit": -11295169000,
      "revenue": 35970935000,
      "sga_expenses": 8196616000,
      "total_assets": 81085699000,
      "total_equity": 28667403000,
      "total_liabilities": 52418296000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [],
  "main_products": "임상, 분석, 비임상, 효능시험 외",
  "phone": "031-326-****",
  "years": [
    2024,
    2023,
    2022
  ]
}